A study looking at the timing of surgery during hormone therapy for breast cancer (EndoNET)

Overview

Cancer types:

Breast cancer

Status:

Open

Phase:

Phase 3

Details

This study is looking at hormone therapy before surgery to help shrink breast cancer.

It is for women who:

  • have a high number of oestrogen receptors on their breast cancer cells ()

  • need both hormone therapy and surgery

  • have been through the

Recruitment start: 23 August 2022

Recruitment end: 30 November 2027

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Michael Douek

Supported by

NIHR Health Technology Assessment (HTA) programme

NIHR Efficacy and Mechanism Evaluation (EME) Programme

University of Oxford

University of Southampton

University of Bristol

Last reviewed: 30 Jun 2026

CRUK internal database number: 19954

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Find a Clinical Trial

Search our clinical trials database for all cancer trials and studies recruiting in the UK.

An icon of two speech bubbles, indicating a conversation.

Cancer Chat forum

Connect with other people affected by cancer and share your experiences.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.